Difficulty: Medium
Average Score: 75%
Practice
In a patient of myocardial infarction, ßadrenergic blockers are used with the following aim/aims:
Correct answer
D
Rationale
In a patient with myocardial infarction, the use of ß-adrenergic blockers serves multiple crucial aims. Option D, "All of the above," is the correct answer because ß-blockers are known to reduce the incidence of reinfarction by decreasing the workload on the heart, preventing cardiac arrhythmias by stabilizing the electrical activity of the heart, and contributing to myocardial salvage by reducing oxygen demand and improving oxygen supply to the heart muscle.
Option A, "To reduce the incidence of reinfarction," is incorrect because while this is one aim of using ß-blockers, it is not the sole purpose. Option B, "To prevent cardiac arrhythmias," is also incorrect as it overlooks the broader benefits of ß-blockers in myocardial infarction beyond just preventing arrhythmias. Option C, "Myocardial salvage," is partially correct as ß-blockers do contribute to salvaging myocardium, but they also have other significant effects on post-myocardial infarction outcomes.
Educationally, understanding the multifaceted benefits of ß-adrenergic blockers in myocardial infarction is essential for healthcare providers managing such patients. By grasping the mechanisms of action of these drugs, clinicians can make informed decisions that optimize patient outcomes and reduce the risk of complications post-myocardial infarction. This knowledge underscores the importance of comprehensive care and pharmacological management in cardiac emergencies.
Option A, "To reduce the incidence of reinfarction," is incorrect because while this is one aim of using ß-blockers, it is not the sole purpose. Option B, "To prevent cardiac arrhythmias," is also incorrect as it overlooks the broader benefits of ß-blockers in myocardial infarction beyond just preventing arrhythmias. Option C, "Myocardial salvage," is partially correct as ß-blockers do contribute to salvaging myocardium, but they also have other significant effects on post-myocardial infarction outcomes.
Educationally, understanding the multifaceted benefits of ß-adrenergic blockers in myocardial infarction is essential for healthcare providers managing such patients. By grasping the mechanisms of action of these drugs, clinicians can make informed decisions that optimize patient outcomes and reduce the risk of complications post-myocardial infarction. This knowledge underscores the importance of comprehensive care and pharmacological management in cardiac emergencies.